US Edition
Walgreens: Fiscal Q3 Earnings Snapshot
LAKE COUNTY, ILLINOIS, JUN 26 – Walgreens reported $39 billion in Q3 sales, up 7.2%, driven by pharmacy and international growth despite a $175 million net loss and ongoing retail declines, company leaders said.
- Walgreens Boots Alliance reports third-quarter sales of $38.99 billion, up 7.2% yoy, with EPS of $0.38 beating estimates as it advances a $23.7 billion deal to go private with Sycamore Partners.
- Walgreens' long-term struggles with declining profitability, nearly $7 billion in debt, and plans to close 1,200 US stores prompted its move to go private through a $23.7 billion deal.
- Walgreens' third quarter saw pharmacy sales rise 11.8% with 14.6% comps, while international revenues increased 7.8% to $6.2 billion; retail sales declined 5.3%, resulting in a $175 million net loss.
- Following the earnings report, Walgreens shares rose 0.9% pre-market as the company withdrew fiscal 2025 guidance, with Evercore ISI stating the acquisition remains unaffected.
- Looking ahead, Walgreens' $23.7 billion deal to go private is set for Q4 2025, with Nasdaq delisting facilitating its turnaround efforts as a private entity.
Insights by Ground AI
Does this summary seem wrong?
23 Articles
23 Articles
Walgreens Beats Earnings Estimates as It Prepares to Go Private
Walgreens Boots Alliance Inc. reported quarterly profit that beat Wall Street’s expectations, a hopeful sign as the pharmacy giant prepares to transform into a private company after its market value plummeted due to retail competition and lower prescription drug payments from insurance companies.
·United States
Read Full Article
Coverage Details
Total News Sources23
Leaning Left3Leaning Right2Center7Last UpdatedBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
58% Center
L 25%
C 58%
R 17%
Factuality
To view factuality data please Upgrade to Premium
